menu search

Qualigen Therapeutics Divests FastPack® Diagnostics Business

Qualigen Therapeutics Divests FastPack® Diagnostics Business
All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX, SA, solidifies Qualigen’s strategic priority on therapeutics CARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announces today […] The post Qualigen Therapeutics Divests FastPack® Diagnostics Business appeared first on Fore... Read More
Posted: Jul 24 2023, 12:15
Author Name: forextv
Views: 092120

Search within

Pages Search Results: